Thr (NASDAQ:THR) | Finanzwire

Basculer en Français

8295	Companies
114831	Keywords
55272	Articles
62429	Press releases

BRIEF

published on 09/03/2024 at 22:15, 2 months 17 days ago

Oxurion begins private judicial reorganization proceedings

Funding Biopharmaceutical Debt Judicial Reorganization Oxurion
PRESS RELEASE

published on 09/03/2024 at 22:10, 2 months 17 days ago

Oxurion Announces the Opening of a Private Judicial Reorganization Procedure
Oxurion NV initiates a private judicial reorganization procedure approved by the Leuven court, aiming to restructure its debts and continue R&D programs. Ilse Van de Mierop appointed as reorganization practitioner

Debt Restructuring Oxurion NV Private Judicial Reorganization R&D Programs Ilse Van De Mierop
BRIEF

published on 09/03/2024 at 18:25, 2 months 17 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Shares Transparency Notification Atlas Special Opportunities Oxurion Belgian Law
PRESS RELEASE

published on 09/03/2024 at 18:20, 2 months 17 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
Oxurion NV receives transparency notifications from Atlas Special Opportunities, LLC regarding changes in shareholding. Company focused on ophthalmic therapies

Transparency Notification Shareholding Atlas Special Opportunities LLC Ophthalmic Therapies Oxurion NV
BRIEF

published on 09/03/2024 at 18:05, 2 months 17 days ago

Oxurion NV Announces Share Consolidation and Key Dates

Share Consolidation Financial Strategy Market Liquidity Trading Dates Oxurion
PRESS RELEASE

published on 09/03/2024 at 18:00, 2 months 17 days ago

Oxurion NV announces date of consolidation of shares and last day of trading of current shares
Oxurion NV confirms the last day of trading for its current shares on Euronext Brussels and details the consolidation of shares on September 3, 2024, to improve market perception and reduce volatility

Financial Structure Euronext Brussels Consolidation Of Shares Oxurion NV Retinal Disease
BRIEF

published on 05/07/2024 at 14:05, 6 months 13 days ago

Thr. Officially Launches Mobile App to Enhance Real-Life Connections

AI Integration Technology Mobile App Networking Real-life Connections
PRESS RELEASE

published on 05/07/2024 at 14:00, 6 months 13 days ago

Business & Social Travel App "Thr." Announces Its Official Product Launch
Thr. redefines human interaction with its market-ready mobile app for turning digital connections into real-world interactions. CEO Eric Creekmore emphasizes the focus on fostering genuine connections and expanding personal and professional networks

Human Connections Thr. App Digital Connections Real-world Interactions Eric Creekmore

Accesswire

Published on 11/21/2024 at 10:03, 36 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 39 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 39 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 4 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 14 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:04, 34 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 37 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 39 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 39 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 38 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 41 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 19 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 54 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 54 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE